Scaglione F - Search Results

1

Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study.

Mangia A, Scaglione F, Toniutto P, Pirisi M, Coppola N, Di Perri G, Alvarez Nieto G, Calabrese S, Hernandez C, Perrone V, Degli Esposti L, Fagiuoli S. Mangia A, et al. Among authors: scaglione f. Int J Environ Res Public Health. 2021 Jul 3;18(13):7144. doi: 10.3390/ijerph18137144. Int J Environ Res Public Health. 2021. PMID: 34281080 Free PMC article.

2

Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.

Degli Esposti L, Sangiorgi D, Buda S, Degli Esposti E, Scaglione F. Degli Esposti L, et al. Among authors: scaglione f. BMJ Open. 2016 Nov 2;6(11):e012003. doi: 10.1136/bmjopen-2016-012003. BMJ Open. 2016. PMID: 27807083 Free PMC article.

3

Re-defining tigecycline therapy.

De Rosa FG, Corcione S, Di Perri G, Scaglione F. De Rosa FG, et al. Among authors: scaglione f. New Microbiol. 2015 Apr;38(2):121-36. Epub 2015 Apr 21. New Microbiol. 2015. PMID: 25915055 Free article. Review.

4

Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.

Minutolo R, Garofalo C, Chiodini P, Aucella F, Del Vecchio L, Locatelli F, Scaglione F, De Nicola L. Minutolo R, et al. Among authors: scaglione f. Nephrol Dial Transplant. 2021 Jan 25;36(2):267-274. doi: 10.1093/ndt/gfaa088. Nephrol Dial Transplant. 2021. PMID: 32829405

5

The impact of drug-drug interactions on pulmonary arterial hypertension therapy.

Ciracì R, Tirone G, Scaglione F. Ciracì R, et al. Among authors: scaglione f. Pulm Pharmacol Ther. 2014 Jun;28(1):1-8. doi: 10.1016/j.pupt.2014.01.004. Epub 2014 Jan 24. Pulm Pharmacol Ther. 2014. PMID: 24462771 Review.

6

Non-interference of xibornol on the theophylline blood levels.

Fraschini F, Scaglione F, Maierna G, Savio G, Gattei G, Falchi M. Fraschini F, et al. Among authors: scaglione f. Int J Clin Pharmacol Res. 1988;8(1):43-6. Int J Clin Pharmacol Res. 1988. PMID: 3366502

7

Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine.

Rucci F, Cigoli MS, Marini V, Fucile C, Mattioli F, Robbiano L, Cavallari U, Scaglione F, Perno CF, Penco S, Marocchi A. Rucci F, et al. Among authors: scaglione f. Drug Metab Pers Ther. 2019 Mar 6;34(1). doi: 10.1515/dmpt-2018-0037. Drug Metab Pers Ther. 2019. PMID: 30840585

8

Individualized treatment of chronic hepatitis C: from research to clinical practice.

Scaglione F, Gonzàlez A, Rizzetto M, Soriano V. Scaglione F, et al. J Chemother. 2006 Mar;18 Spec no. 1:5-29. doi: 10.1080/1120009x.2006.11782407. J Chemother. 2006. PMID: 17058849 No abstract available.

9

Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections.

Scaglione F, Demartini G, Cocuzza C, Raschi S, Cogo R. Scaglione F, et al. Int J Clin Pharmacol Res. 1995;15(3):121-5. Int J Clin Pharmacol Res. 1995. PMID: 8847153 Clinical Trial.

10

Ibrutinib: from bench side to clinical implications.

Grisafi D, Maestro A, Grumi C, Piazzoni L, Tirone G, Fiore W, Tessari R, Gianardi V, Gatti M, Tasca F, Generali D, Ravelli A, Lanza F, Scaglione F. Grisafi D, et al. Among authors: scaglione f. Med Oncol. 2015 Sep;32(9):225. doi: 10.1007/s12032-015-0669-9. Epub 2015 Jul 30. Med Oncol. 2015. PMID: 26223732 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page